Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
Q1 2026 earnings • released • EPS beat +1.62% • Revenue beat +0.60%
See results
BSX:NYSE
Boston Scientific Corp
$65.69
+1.26%
(+0.82) 1D
$65.41
-0.43% (-0.28)
Pre-market
Closed: Apr 23, 4:00:08 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BSX...
Open
$65.57
High
$66.88
Low
$64.93
Mkt. cap
97.63B
Avg. vol.
15.24M
Volume
7.24K
P/E ratio
27.55
52-wk high
$109.50
52-wk low
$59.38
EPS
$2.38
Beta
0.78
Shares outstanding
1.49B
No. of employees
59K
News stories
From sources across the web
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com
Last report
Apr 22, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0.80/ (0.79 est.)USD
+1.62%beat
Revenue / Estimate
5.20B/ (5.17B est.)USD
+0.60%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.06B
5.06B
5.29B
5.20B
Cost of goods sold
1.65B
1.54B
1.61B
1.55B
Cost of revenue
1.65B
1.54B
1.61B
1.55B
Research and development expenses
526.00M
514.00M
569.00M
516.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.72B
1.74B
1.83B
1.78B
Operating expense
2.47B
2.48B
2.63B
2.53B
Total operating expenses
4.12B
4.02B
4.24B
4.08B
Operating income
943.00M
1.05B
1.04B
1.12B
Other non operating income
440.00M
-16.00M
28.00M
-19.00M
EBT including unusual items
941.00M
938.00M
700.00M
1.16B
EBT excluding unusual items
1.29B
935.00M
1.01B
1.01B
Income tax expense
146.00M
183.00M
30.00M
-176.00M
Effective tax rate
15.52%
19.51%
4.29%
-15.13%
Other operating expenses
-
-
-
-
Net income
797.00M
755.00M
672.00M
1.34B
Net profit margin
15.75%
14.91%
12.71%
25.77%
Earnings per share
0.75
0.75
0.80
0.80
Interest and investment income
-
-
29.00M
-
Interest expense
-90.00M
-87.00M
-90.00M
-90.00M
Net interest expenses
-90.00M
-87.00M
-61.00M
-90.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.28B
1.39B
1.41B
1.46B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer